Related references
Note: Only part of the references are listed.Dynamic Regulation of Long-Chain Fatty Acid Oxidation by a Noncanonical Interaction between the MCL-1 BH3 Helix and VLCAD
Silvia Escudero et al.
MOLECULAR CELL (2018)
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth
Patrick Casara et al.
Oncotarget (2018)
BCL-2 family proteins: changing partners in the dance towards death
Justin Kale et al.
CELL DEATH AND DIFFERENTIATION (2018)
BCL-XL directly modulates RAS signalling to favour cancer cell stemness
Sophie de Carne Trecesson et al.
NATURE COMMUNICATIONS (2017)
Found in Translation : How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax
Joel D. Leverson et al.
CANCER DISCOVERY (2017)
Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
CLINICAL CANCER RESEARCH (2017)
BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation
Fabien Llambi et al.
CELL (2016)
Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death
Giampaolo Morciano et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
Elizabeth A. Punnoose et al.
MOLECULAR CANCER THERAPEUTICS (2016)
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Andras Kotschy et al.
NATURE (2016)
BCL2 gene polymorphisms and splicing variants in chronic myeloid leukemia
Vicent Guillem et al.
LEUKEMIA RESEARCH (2015)
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
Joel D. Leverson et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
S. Besbes et al.
CELL DEATH & DISEASE (2015)
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
J. D. Leverson et al.
CELL DEATH & DISEASE (2015)
Cell and Molecular Determinants of In Vivo Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts
Santi Suryani et al.
CLINICAL CANCER RESEARCH (2014)
The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis
Pamela Bielli et al.
EMBO REPORTS (2014)
Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5′ splice site selection
Pamela Bielli et al.
NUCLEIC ACIDS RESEARCH (2014)
被撤回的出版物: Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis (Retracted article. See vol. 44, pg. 9518, 2016)
Carlos DeOcesano-Pereira et al.
NUCLEIC ACIDS RESEARCH (2014)
Overexpression of Mcl-1L Splice Variant Is Associated with Poor Prognosis and Chemoresistance in Oral Cancers
Vinayak Palve et al.
PLOS ONE (2014)
Chemical Perturbation of Mcl-1 Pre-mRNA Splicing to Induce Apoptosis in Cancer Cells
Yang Gao et al.
ACS CHEMICAL BIOLOGY (2013)
Protect and serve Bcl-2 proteins as guardians and rulers of cancer cell survival
Frederique Braun et al.
CELL CYCLE (2013)
Modification of Akt by SUMO conjugation regulates alternative splicing and cell cycle
Guillermo Risso et al.
CELL CYCLE (2013)
Direct Interaction of Bax and Bak Proteins with Bcl-2 Homology Domain 3 (BH3)-only Proteins in Living Cells Revealed by Fluorescence Complementation
Laura Vela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
An Interaction between Bcl-xL and the Voltage-dependent Anion Channel (VDAC) Promotes Mitochondrial Ca2+ Uptake
Huiya Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Structure-guided design of a selective BCL-XL inhibitor
Guillaume Lessene et al.
NATURE CHEMICAL BIOLOGY (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
MCL-1ES Induces MCL-1L-Dependent BAX- and BAK-Independent Mitochondrial Apoptosis
Jae-Hong Kim et al.
PLOS ONE (2013)
BCL2 Suppresses PARP1 Function and Nonapoptotic Cell Death
Chaitali Dutta et al.
CANCER RESEARCH (2012)
Disruption of the VDAC2-Bak interaction by Bcl-xS mediates efficient induction of apoptosis in melanoma cells
M. Ploetz et al.
CELL DEATH AND DIFFERENTIATION (2012)
Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
Charles M. Rudin et al.
CLINICAL CANCER RESEARCH (2012)
Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
Andrew W. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
TCERG1 Regulates Alternative Splicing of the Bcl-x Gene by Modulating the Rate of RNA Polymerase II Transcription
Marta Montes et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Distinct roles of mitochondria- and ER-localized Bcl-xL in apoptosis resistance and Ca2+ homeostasis
Colins O. Eno et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
The secret life of Bcl-2: Apoptosis-independent inhibition of DNA repair by Bcl-2 family members
Corentin Laulier et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2012)
Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak
C. Wang et al.
ONCOGENE (2012)
Regulation of the Autophagic Bcl-2/Beclin 1 Interaction
Jean-Paul Decuypere et al.
Cells (2012)
Molecular biology of Bax and Bak activation and action
Dana Westphal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
BH3-only proteins: Orchestrators of apoptosis
Aisha Shamas-Din et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Bcl-2 Inhibits Nuclear Homologous Recombination by Localizing BRCA1 to the Endomembranes
Corentin Laulier et al.
CANCER RESEARCH (2011)
The DNA Damage Response Pathway Regulates the Alternative Splicing of the Apoptotic Mediator Bcl-x
Lulzim Shkreta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
Leena Gandhi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
Fabien Llambi et al.
MOLECULAR CELL (2011)
Molecular Basis of Bcl-XL-p53 Interaction: Insights from Molecular Dynamics Simulations
Nagakumar Bharatham et al.
PLOS ONE (2011)
Mcl-1 levels need not be lowered for cells to be sensitized for ABT-263/737-induced apoptosis
R. Yamaguchi et al.
CELL DEATH & DISEASE (2011)
An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis
Michael J. Moore et al.
CELL (2010)
Mcl-1; the molecular regulation of protein function
Luke W. Thomas et al.
FEBS LETTERS (2010)
Apoptosis Protection by Mcl-1 and Bcl-2 Modulation of Inositol 1,4,5-Trisphosphate Receptor-dependent Ca2+ Signaling
Emily F. Eckenrode et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Anti-apoptotic Protein BCL2 Down-regulates DNA End Joining in Cancer Cells
Tadi Satish Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Wyndham H. Wilson et al.
LANCET ONCOLOGY (2010)
Anti-tumor activity of splice-switching oligonucleotides
John A. Bauman et al.
NUCLEIC ACIDS RESEARCH (2010)
LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
Sanjiv S. Agarwala et al.
EUROPEAN JOURNAL OF CANCER (2009)
MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death
Jae-Hong Kim et al.
FEBS LETTERS (2009)
Heterogeneous Nuclear Ribonucleoprotein K Represses the Production of Pro-apoptotic Bcl-xS Splice Isoform
Timothee Revil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Modification of Alternative Splicing of Mcl-1 Pre-mRNA Using Antisense Morpholino Oligonucleotides Induces Apoptosis in Basal Cell Carcinoma Cells
Jeng-Jer Shieh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Bcl-2 protein family members: Versatile regulators of calcium signaling in cell survival and apoptosis
Yiping Rong et al.
ANNUAL REVIEW OF PHYSIOLOGY (2008)
Apoptosis induction by Bcl-2 proteins independent of the BH3 domain
Amir M. Hossini et al.
BIOCHEMICAL PHARMACOLOGY (2008)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35
G. Merdzhanova et al.
CELL DEATH AND DIFFERENTIATION (2008)
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth
Julia Schultz et al.
CELL RESEARCH (2008)
Bcl2 inhibits abasic site repair by down-regulating APE1 endonuclease activity
Jinfeng Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Antagonistic effects of the SRp30c protein and cryptic 5′ splice sites on the alternative splicing of the apoptotic regulator Bcl-x
Philippe Cloutier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein phosphatase 1 activation and alternative splicing of Bcl-x and Mcl-1 by EGCG plus ibuprofen
Myoung H. Kim
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5′ splice site selection
AnYu Zhou et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway
Qinhong Wang et al.
MOLECULAR CELL (2008)
JNK1-mediated phosphorylation of BcI-2 regulates starvation-induced autophagy
Yongjie Wei et al.
MOLECULAR CELL (2008)
BCL-2 family antagonists for cancer therapy
Guillaume Lessene et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
The daily job of night killers: alternative roles of the BCL-2 family in organelle physiology
Claudio Hetz et al.
TRENDS IN CELL BIOLOGY (2008)
Protein kinase C-dependent control of Bcl-x alternative splicing
Timothee Revil et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism
Kritsanapol Boon-Unge et al.
CHEMISTRY & BIOLOGY (2007)
Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes
Brian Leber et al.
APOPTOSIS (2007)
Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells
Geoffrey A. Bartholomeusz et al.
BLOOD (2007)
Structural insights into the degradation of Mcl-1 induced by BH3 domains
Peter E. Czabotar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Bcl2 impedes DNA mismatch repair by directly regulating the hMSH2-hMSH6 heterodimeric complex
Yongzhong Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x
Maria Paola Paronetto et al.
JOURNAL OF CELL BIOLOGY (2007)
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak
Simon N. Willis et al.
SCIENCE (2007)
Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities
J. C. Reed
CELL DEATH AND DIFFERENTIATION (2006)
SAP155 binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5′ splice site selection of Bcl-x pre-mRNA
Autumn Massiello et al.
FASEB JOURNAL (2006)
Bcl2 Suppresses DNA Repair by Enhancing c-Myc Transcriptional Activity
Zhaohui Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain
AM Hossini et al.
ONCOGENE (2006)
How the Bcl-2 family of proteins interact to regulate apoptosis
MF van Delft et al.
CELL RESEARCH (2006)
The endoplasmic reticulum gateway to apoptosis by Bcl-XL modulation of the InsP3R
C White et al.
NATURE CELL BIOLOGY (2005)
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy
S Pattingre et al.
CELL (2005)
Bak but not Bax is essential for Bcl-xs-induced apoptosis
L Lindenboim et al.
CELL DEATH AND DIFFERENTIATION (2005)
Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x
D Garneau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands
CL Day et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Bcl-2 expression suppresses mismatch repair activity through inhibition of E2F transcriptional activity
CK Youn et al.
NATURE CELL BIOLOGY (2005)
Identification of two RNA cis-elements that function to regulate the 5′ splice site selection of Bcl-x pre-mRNA in response to ceramide
A Massiello et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structural biology of the Bcl-2 family of proteins
AM Petros et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
JE Chipuk et al.
SCIENCE (2004)
Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis
L España et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2
CA Massaad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA
CY Li et al.
CELL RESEARCH (2004)
Anti-apoptotic protein Bcl-2 interacts with and destabilizes the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA)
ES Dremina et al.
BIOCHEMICAL JOURNAL (2004)
Conditional expression of exogenous Bcl-Xs triggers apoptosis in human melanoma cells in vitro and delays growth of melanoma xenografts
AM Hossini et al.
FEBS LETTERS (2003)
Transmembrane domain of Bcl-2 is required for inhibition of ceramide synthesis, but not cytochrome c release in the pathway of inostamycin-induced apoptosis
M Kawatani et al.
EXPERIMENTAL CELL RESEARCH (2003)
Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death
JK Ko et al.
ONCOGENE (2003)
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane
T Kuwana et al.
CELL (2002)
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
A Letai et al.
CANCER CELL (2002)
Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology
C Belka et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2002)
Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis
A Nechushtan et al.
JOURNAL OF CELL BIOLOGY (2001)
Solution structure of the antiapoptotic protein bcl-2
AM Petros et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain
J Bae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Exon skipping in Mcl-1 results in a Bcl-2 homology domain 3 only gene product that promotes cell death
CD Bingle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells
JL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax
S Kagawa et al.
GENE THERAPY (2000)
Share Paper
